SCHEMBL31480262

SCHEMBL31480262

CNc1cc(C(=O)OC)ccc1C1CC2(CCN1)CC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 4/20 0.38
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
MAPKAPK2 P49137 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
XDH P47989 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
HSD17B10 Q99714 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
RAB9A P51151 2/20 0.34
KIF11 P52732 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31480286 0.92 ALDH1A1 (0.36) ALDH1A1KDM4EMAPTNPSR1CHRNB2
SCHEMBL31480080 0.81 KMT2A (0.36) ALDH1A1KDM4EMAPTNPSR1CHRNB2
SCHEMBL31480229 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTNPSR1CHRNB2
SCHEMBL31480467 0.79 ALDH1A1 (0.35) ALDH1A1KDM4EMAPTNPSR1CHRNB2
SCHEMBL31480447 0.79 MAPT (0.33) ALDH1A1KDM4EMAPTNPSR1CHRNB2
SCHEMBL16400464 0.79 NPC1 (0.45) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL31480315 0.78 NISCH (0.37) ALDH1A1KDM4EMAPTNPSR1CHRNB2
SCHEMBL31480330 0.77 PTGER4 (0.37) ALDH1A1KDM4EMAPTNPSR1CHRNB2
SCHEMBL31480332 0.76 CRBN (0.32) MAPTSMN1; SMN2RAB9ANPC1
SCHEMBL31480509 0.76 CRBN (0.32) MAPTSMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054361-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2025-03-13 WO disclosed